Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02423109 · ClinicalTrials.gov registry record · NA

Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses

A NA study, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
44
Enrollment target

NCT02423109 is a NA study that has completed, run by CooperVision. The registered enrollment target is 44 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02423109, a NA study, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

Bilateral dispensing clinical trial of fanfilcon A toric lens verses enfilcon A toric lens over two weeks.

Interventions

  • DEVICE enfilcon A
  • DEVICE fanfilcon A

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2015-09
Est. Completion 2016-03
Phase NA

Sponsor

CooperVision

64 total trials

What the Registry Record Tells You About NCT02423109

The ClinicalTrials.gov registry entry for NCT02423109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which enfilcon A is the first listed.

NCT02423109 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02423109 about?

NCT02423109 is a clinical study titled "Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses". Bilateral dispensing clinical trial of fanfilcon A toric lens verses enfilcon A toric lens over two weeks.

What is the current status of trial NCT02423109?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-09. Estimated completion is 2016-03.

What interventions are being tested in trial NCT02423109?

The interventions under investigation include: enfilcon A (DEVICE), fanfilcon A (DEVICE).

Who is sponsoring clinical trial NCT02423109?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.